Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OVID

Ovid Therapeutics

$6.20

0.22 (3.68%)

12:55
08/10/18
08/10
12:55
08/10/18
12:55
Recommendations
Ovid Therapeutics analyst commentary at Piper Jaffray »

Piper sees value coming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
OVID

Ovid Therapeutics

$6.00

-0.04 (-0.66%)

16:05
08/09/18
08/09
16:05
08/09/18
16:05
Earnings
Ovid Therapeutics reports Q2 EPS (53c), consensus (60c) »

As of June 30, cash, cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$6.19

-3.36 (-35.18%)

15:12
08/06/18
08/06
15:12
08/06/18
15:12
Recommendations
Ovid Therapeutics analyst commentary at Piper Jaffray »

Ovid Therapeutics shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

OVID

Ovid Therapeutics

$9.55

-0.15 (-1.55%)

07:33
08/06/18
08/06
07:33
08/06/18
07:33
Conference/Events
Ovid Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

OVID

Ovid Therapeutics

$9.55

-0.15 (-1.55%)

07:30
08/06/18
08/06
07:30
08/06/18
07:30
Hot Stocks
Breaking Hot Stocks news story on Ovid Therapeutics »

Ovid Therapeutics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$9.55

-0.15 (-1.55%)

07:13
08/06/18
08/06
07:13
08/06/18
07:13
Hot Stocks
Ovid Therapeutics says Phase 2 STARS Trial of OV101 achieved primary endpoint »

Ovid Therapeutic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$9.55

-0.15 (-1.55%)

06:57
08/06/18
08/06
06:57
08/06/18
06:57
Hot Stocks
Breaking Hot Stocks news story on Ovid Therapeutics »

Ovid Therapeutics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
OVID

Ovid Therapeutics

$9.70

0.37 (3.97%)

16:05
07/11/18
07/11
16:05
07/11/18
16:05
Hot Stocks
Ovid Therapeutics to present OV101 data at NFXF »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$65.29

3.18 (5.12%)

, KPTI

Karyopharm

$19.54

0.7503 (3.99%)

04:55
06/21/18
06/21
04:55
06/21/18
04:55
Conference/Events
JMP Securities to hold a conference »

Life Sciences Conference…

CRSP

Crispr Therapeutics

$65.29

3.18 (5.12%)

KPTI

Karyopharm

$19.54

0.7503 (3.99%)

NTLA

Intellia Therapeutics

$30.76

1.79 (6.18%)

IOVA

Iovance Biotherapeutics

$13.60

0.15 (1.12%)

OVID

Ovid Therapeutics

$8.69

0.475 (5.78%)

RTRX

Retrophin

$28.00

-0.39 (-1.37%)

MYOV

Myovant Sciences

$24.95

1.21 (5.10%)

ARPO

Aerpio Pharmaceuticals

$0.00

(0.00%)

CRBP

Corbus Pharmaceuticals

$5.95

-0.1 (-1.65%)

PFNX

Pfenex

$5.20

-0.425 (-7.56%)

OCUL

Ocular Therapeutix

$7.90

-0.12 (-1.50%)

SVRA

Savara

$13.72

0.19 (1.40%)

SNDX

Syndax

$8.22

-0.12 (-1.44%)

AVDL

Avadel Pharmaceuticals

$7.53

0.11 (1.48%)

HALO

Halozyme

$19.47

0.3 (1.56%)

EYEN

Eyenovia

$8.24

0.19 (2.36%)

NVTR

Nuvectra

$23.03

0.8 (3.60%)

MLNT

Melinta Therapeutics

$7.90

(0.00%)

ENTA

Enanta

$115.27

1.16 (1.02%)

ACRS

Aclaris Therapeutics

$20.31

0.47 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

CRSP

Crispr Therapeutics

$62.11

-0.52 (-0.83%)

, KPTI

Karyopharm

$18.79

0.1597 (0.86%)

08:50
06/20/18
06/20
08:50
06/20/18
08:50
Conference/Events
JMP Securities to hold a conference »

Life Sciences Conference…

CRSP

Crispr Therapeutics

$62.11

-0.52 (-0.83%)

KPTI

Karyopharm

$18.79

0.1597 (0.86%)

NTLA

Intellia Therapeutics

$28.97

0.01 (0.03%)

IOVA

Iovance Biotherapeutics

$13.45

(0.00%)

OVID

Ovid Therapeutics

$8.22

0.15 (1.86%)

RTRX

Retrophin

$28.39

-0.04 (-0.14%)

MYOV

Myovant Sciences

$23.74

0.375 (1.61%)

ARPO

Aerpio Pharmaceuticals

$0.00

(0.00%)

CRBP

Corbus Pharmaceuticals

$6.05

-0.05 (-0.82%)

PFNX

Pfenex

$5.63

0.185 (3.40%)

OCUL

Ocular Therapeutix

$8.02

(0.00%)

SVRA

Savara

$13.53

0.09 (0.67%)

SNDX

Syndax

$8.34

-0.03 (-0.36%)

AVDL

Avadel Pharmaceuticals

$7.42

-0.05 (-0.67%)

HALO

Halozyme

$19.17

0.25 (1.32%)

EYEN

Eyenovia

$8.05

0.25 (3.21%)

NVTR

Nuvectra

$22.23

0.1 (0.45%)

MLNT

Melinta Therapeutics

$7.90

-0.2 (-2.47%)

ENTA

Enanta

$114.11

0.14 (0.12%)

ACRS

Aclaris Therapeutics

$19.84

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.